QuidelOrtho Corp.

20
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2197981051
USD
19.12
1.47 (8.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
2,727.00
2,785.00
2,993.00
3,263.00
1,698.00
1,661.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,727.00
2,785.00
2,993.00
3,263.00
1,698.00
1,661.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
195.00
217.00
117.00
74.00
0.00
1.00
General and Administration Expenses
746.00
766.00
763.00
621.00
259.00
199.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2,577.00
2,685.00
2,720.00
2,273.00
782.00
596.00
Operating Profit (PBDIT) excl Other Income
149.00
100.00
273.00
989.00
915.00
1,065.00
Other Income
15.00
43.00
-44.00
-7.00
-5.00
-8.00
Operating Profit (PBDIT)
509.00
545.00
659.00
1,253.00
965.00
1,106.00
Interest
195.00
217.00
117.00
74.00
0.00
1.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
442.00
453.00
457.00
283.00
54.00
49.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-1,107.00
-2,131.00
-29.00
735.00
900.00
1,040.00
Provision for Tax
24.00
-79.00
-19.00
187.00
196.00
230.00
Profit After Tax
-1,131.00
-2,052.00
-10.00
548.00
704.00
810.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-16.69
-30.54
-0.15
9.56
16.43
18.60
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -2.10% vs -6.95% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 48.90% vs -63.28% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -9.72% vs 84.68% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is 44.84% vs -20,216.83% in Dec 2024

Compare Profit and Loss Results of QuidelOrtho Corp.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
2,727.00
2,306.00
421.00
18.26%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,727.00
2,306.00
421.00
18.26%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
195.00
4.00
191.00
4,775.00%
General and Administration Expenses
746.00
1,173.00
-427.00
-36.40%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2,577.00
2,612.00
-35.00
-1.34%
Operating Profit (PBDIT) excl Other Income
149.00
-306.00
455.00
148.69%
Other Income
15.00
45.00
-30.00
-66.67%
Operating Profit (PBDIT)
509.00
-216.00
725.00
335.65%
Interest
195.00
4.00
191.00
4,775.00%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
442.00
43.00
399.00
927.91%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-1,107.00
-268.00
-839.00
-313.06%
Provision for Tax
24.00
-59.00
83.00
140.68%
Profit After Tax
-1,131.00
-208.00
-923.00
-443.75%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-16.6932
-1.5225
-15.17
-996.43%
Profit And Loss - Net Sales
Net Sales 2,727.00 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -2.10% vs -6.95% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 149.50 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 48.90% vs -63.28% in Dec 2024

Profit And Loss - Interest
Interest 195.90 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -9.72% vs 84.68% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax -1,131.80 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 44.84% vs -20,216.83% in Dec 2024